Antisoma PLC (ASM.L)
-LSE 1.60 
0.20(13.93%) 3:43AM EDT
| Prev Close: | 1.40 |
|---|
| Open: | 1.41 |
|---|
| Bid: | 1.40 |
|---|
| Ask: | 1.70 |
|---|
| 1y Target Est: | 17.00 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.40 - 1.50 |
|---|
| 52wk Range: | 1.30 - 2.10 |
|---|
| Volume: | 55,000 |
|---|
| Avg Vol (3m): | 100,181 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Antisoma Plc does not have significant operations. It intends to evaluate various new commercial and acquisition opportunities. Previously, the company was engaged in the development of novel drugs for the treatment of cancer.
View More